Advanced search
Publication Cover
Current Medical Research and Opinion Volume 36, 2020 - Issue 2
Submit an article Journal homepage
528
Views
4
CrossRef citations to date
0
Altmetric
Neurology

Time to treatment failure following initiation of fingolimod versus teriflunomide for multiple sclerosis: a retrospective US claims study

Maria Cecilia VieiraHealth Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;
,
Devon ConwayMellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA; Correspondence[email protected]
,
Gina Mavrikis CoxHealth Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;
,
Miranda PeeplesHealth Economics and Outcomes Research, Analysis Group Inc., Boston, MA, USA
,
Arielle G. BensimonHealth Economics and Outcomes Research, Analysis Group Inc., Boston, MA, USA
,
Monica MachecaHealth Economics and Outcomes Research, Analysis Group Inc., Boston, MA, USA
&
Vivian HerreraHealth Economics and Outcomes Research, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;
show all
Pages 261-270 | Received 11 Feb 2019, Accepted 05 Nov 2019, Published online: 05 Dec 2019

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Giancarlo Comi, Gloria Dalla Costa & Lucia Moiola. (2021) Newly approved agents for relapsing remitting multiple sclerosis: how real-world evidence compares with randomized clinical trials?. Expert Review of Neurotherapeutics 21:1, pages 21-34.
Read now
Carrie M. Hersh, Richard A. Brook, Ian A. Beren, Nicholas J. Rohrbacker, Lori Lebson, Christian Henke & Amy L. Phillips. (2021) The implications of suboptimal year-1 outcomes with disease-modifying therapy in employees with multiple sclerosis. Journal of Medical Economics 24:1, pages 479-486.
Read now

Articles from other publishers (2)

Joshua MardanMohammad Akhtar HussainMichelle AllanLisa B Grech. (2021) Objective medication adherence and persistence in people with multiple sclerosis: a systematic review, meta-analysis, and meta-regression. Journal of Managed Care & Specialty Pharmacy 27:9, pages 1273-1295.
Crossref
Julie Beyrer, Janna Manjelievskaia, Machaon Bonafede, Gregory Lenhart, Sandra Nolot, Diane Haldane & Joseph Johnston. (2021) Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data. Pharmacoepidemiology and Drug Safety 30:5, pages 582-593.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.